Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

This study tests an experimental inhaler called TQC3721 in 195 adults aged 40-80 with moderate to severe COPD. The main goal is to see if it improves lung function (measured by FEV1) over 4 weeks compared to a placebo. Participants use a dry powder inhaler and are monitored for s…

This study tests whether adding an experimental drug (TQB3616) to standard hormone therapy (fulvestrant) can delay cancer growth in people with a common type of advanced breast cancer (HR-positive, HER2-negative). About 432 participants will receive either the drug combo or a pla…

This study tests whether adding an experimental tablet (TQ-A3334) to standard antiviral therapy can better control chronic hepatitis B virus. About 116 adults with long-term HBV infection will receive either the new drug or a placebo, plus their usual medication. The main goal is…

This study tests a new tablet called TQ05105 against a standard drug, hydroxyurea, in people with moderate to high-risk myelofibrosis, a type of bone marrow cancer. The main goal is to see if TQ05105 can shrink the spleen by at least 35% after 24 weeks. About 107 adults aged 18-7…

This study tests an experimental tablet called TQ05105 in 45 adults with moderate to severe chronic graft-versus-host disease (cGVHD) that hasn't improved with steroids. The goal is to find the best dose and see if it can control the disease and ease symptoms. Participants take t…